GOVX
$3.89
Geovax Labs
$.07
1.83%
GOVX
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Thursday
Nov 4
5:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when GOVX reports earnings?
Beat
Meet
Miss

Where is GOVX's stock price going from here?
Up
Flat
Down
Stock chart of GOVX
Analysts
Summary of analysts' recommendations for GOVX
Score
Grade
Pivots
Resistance
$3.99
$3.93
$3.88

$3.82

Support
$3.76
$3.71
$3.65
Tweet
Growth
Description
GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.
Peers
Vertex PharmaceuticalsUltragenyx PharmaceuticalRegeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbInterCeptMerck & Co.Eli LillyZoetisPfizer